We are live on ! Find out more
SSWM

Smith Salley Wealth Management Portfolio holdings

AUM $2.3B
1-Year Est. Return 38.65%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+38.65%
3 Year Est. Return
+105.94%
5 Year Est. Return
+133.49%
10 Year Est. Return
+415.99%
AUM
$497M
AUM Growth
+$9.63M
Cap. Flow
+$1.87M
Cap. Flow %
0.38%
Top 10 Hldgs %
24.08%
Holding
178
New
5
Increased
63
Reduced
86
Closed
7

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$4.24M
2
AME icon
Ametek
AME
+$4.14M
3
SNA icon
Snap-on
SNA
+$3.94M
4
FBNC icon
First Bancorp
FBNC
+$3.34M
5
SKT icon
Tanger
SKT
+$2.41M

Sector Composition

Rank Sector Weight
1 Financials 17.79%
2 Healthcare 15.49%
3 Technology 14.19%
4 Industrials 12.26%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
51
Emerson Electric
EMR
$89B
$3.71M 0.75%
62,232
-534
-0.9% -$31.7K
T icon
52
AT&T
T
$160B
$3.69M 0.74%
129,684
+3,893
+3% +$115K
DUK icon
53
Duke Energy
DUK
$96.9B
$3.53M 0.71%
42,257
+9,923
+31% +$834K
FBNC icon
54
First Bancorp
FBNC
$2.71B
$3.53M 0.71%
+112,894
New +$3.34M
MGA icon
55
Magna International
MGA
$18.7B
$3.5M 0.7%
75,465
-2,312
-3% -$100K
DEO icon
56
Diageo
DEO
$48.8B
$3.46M 0.7%
28,880
-92
-0.3% -$11K
ENB icon
57
Enbridge
ENB
$117B
$3.45M 0.69%
86,755
+96
+0.1% +$3.87K
AMGN icon
58
Amgen
AMGN
$210B
$3.36M 0.68%
19,529
+472
+2% +$76.8K
QCOM icon
59
Qualcomm
QCOM
$171B
$3.36M 0.68%
60,890
+1,652
+3% +$92.3K
CVX icon
60
Chevron
CVX
$379B
$3.34M 0.67%
32,052
+890
+3% +$94.3K
GSK icon
61
GSK
GSK
$103B
$3.26M 0.66%
60,462
+1,404
+2% +$74.8K
MDU icon
62
MDU Resources
MDU
$4.2B
$3.15M 0.63%
315,854
+1,825
+0.6% +$18.7K
PRGO icon
63
Perrigo
PRGO
$1.49B
$3.11M 0.63%
41,178
-758
-2% -$54.4K
KMB icon
64
Kimberly-Clark
KMB
$37B
$3.02M 0.61%
23,379
+385
+2% +$50.1K
NVS icon
65
Novartis
NVS
$291B
$3.01M 0.61%
40,276
+1,190
+3% +$84.3K
VFC icon
66
VF Corp
VFC
$5.99B
$2.91M 0.58%
53,584
+352
+0.7% +$18.2K
VZ icon
67
Verizon
VZ
$195B
$2.81M 0.57%
62,993
-1,105
-2% -$51.5K
ETN icon
68
Eaton
ETN
$173B
$2.78M 0.56%
35,675
+381
+1% +$29K
F icon
69
Ford
F
$56.8B
$2.7M 0.54%
241,419
+8,761
+4% +$97.8K
VGT icon
70
Vanguard Information Technology ETF
VGT
$147B
$2.63M 0.53%
149,504
+664
+0.4% +$11.7K
INTC icon
71
Intel
INTC
$509B
$2.59M 0.52%
76,789
+1,365
+2% +$48.8K
UL icon
72
Unilever
UL
$138B
$2.58M 0.52%
42,472
+1,813
+4% +$108K
STX icon
73
Seagate
STX
$192B
$2.55M 0.51%
65,820
+430
+0.7% +$18.8K
DOC icon
74
Healthpeak Properties
DOC
$14.9B
$2.52M 0.51%
78,858
+26
+0% +$824
RDS.A
75
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.46M 0.49%
46,254
-101
-0.2% -$5.41K

Similar funds

Smith Salley Wealth Management's Q2 2017 Portfolio in Review

As of Q2 2017, Smith Salley Wealth Management held 178 positions worth $497M, up 2% from $488M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Smith Salley Wealth Management's Q2 2017 filing shows 5 new, 63 increased, 86 reduced and 7 closed positions. Its largest new stake was Snap-on: 24,054 shares worth $3.8M. The largest sale was Express Scripts Holding Company, an estimated $4.94M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

  • Smith Salley Wealth Management's largest Q2 2017 buy was Snap-on: 24,054 shares worth $3.8M.
  • Smith Salley Wealth Management added most to Thermo Fisher Scientific in Q2 2017, an estimated $4.24M increase.
  • Smith Salley Wealth Management's biggest Q2 2017 reduction was American International, cutting an estimated $4.44M.
  • Smith Salley Wealth Management fully exited Express Scripts Holding Company in Q2 2017, selling an estimated $4.94M.
  • Smith Salley Wealth Management's ten largest holdings make up 24% of its $497M portfolio in Q2 2017.
  • Smith Salley Wealth Management opened 5 new positions and closed 7 in Q2 2017.
  • Smith Salley Wealth Management's portfolio value rose 2% quarter-over-quarter to $497M.

Based on Smith Salley Wealth Management's 13F filing for Q2 2017, filed 25 Jul 2017.